Celiac.com Sponsor (A1):


Join eNewsletter


Celiac.com Sponsor (A1-m):



Join eNewsletter

Archived

This topic is now archived and is closed to further replies.

Scott Adams

NIH awards Avaxia Phase I SBIR grant to develop novel antibody therapeutic for ... - News-Medical.net

Recommended Posts

NIH awards Avaxia Phase I SBIR grant to develop novel antibody therapeutic for ...

News-Medical.net

"We are delighted to have been awarded this grant from the NIH in recognition of the potential of our novel approach to the treatment of celiac disease," said Barbara S. Fox, Ph.D., Avaxia's founder and CEO. "This NIH support provides the funding we ...

Avaxia Biologics gets Phase I SBIR grant Pharmaceutical Business Review

all 4 news articles »

View the full article


Scott Adams

Celiac.com - Celiac Disease Board Moderator

Founder Celiac.com

Share this post


Link to post
Share on other sites

Celiac.com Sponsor (A8):

Celiac.com Sponsor (A8):